Actualités Mar 18, 2024 Neuria intègre l’accélérateur Vanguard pour promouvoir des modes de vie plus sains Neuria Digital Therapeutics est la première start-up de 2024 à bénéficier du programme Vanguard Accelerator.
Innovation Switzerland Innovation Parks Switzerland Innovation’s technology parks are the ideal location for research-oriented companies to develop their next groundbreaking or highly p...
News Nov 03, 2023 EPFL and Novochizol to collaborate on designing more efficient immunotherapies A groundbreaking collaboration between EPFL's Laboratory of Biomaterials for Immunoengineering and Novochizol aims to revolutionize cancer treatm...
Exemples de Réussite May 02, 2024 Comment BeiGene favorise l’accès au traitement du cancer à l’échelle mondiale Depuis son siège européen à Bâle, en Suisse, BeiGene collabore de manière stratégique avec des parties prenantes dans le monde entier pour f...
Aktuell Nov 03, 2023 CSL wird Teil des Basler Biotech-Clusters Die Abteilung für Forschung und Entwicklung des weltweit tätigen australischen Biotech-Unternehmens CSL hat im Switzerland Innovation Park Basel ...
News Aug 23, 2023 Forty51 Ventures provides the financial backing to found Mysthera Therapeutics Mysthera Therapeutics AG has been founded in Basel. Forty51 Ventures, a venture capital firm also based in Basel, has provided 3.5 million US dol...
Aktuell Aug 28, 2023 Positrigo erleichtert Bildgebung des Gehirns Das Medtech-Unternehmen Positrigo stellt im September sein neues Gerät zur Bildgebung des Gehirns vor. Mit NeuroLF soll die Diagnose und auch Übe...
News Jun 02, 2023 Sandoz decides on Basel for headquarters Sandoz AG will continue to have its headquarters in Basel as an independent company. The separation from Novartis is expected to take place in th...
News May 15, 2024 Allegria Therapeutics raises 3.5 million dollars in seed financing round Allegria Therapeutics has received seed funding of 3.5 million dollars from the founding investor Forty51 Ventures. The biotech startup is develo...
News May 07, 2024 UZH researching innovative cancer therapy Researchers from the University of Zurich (UZH) are in the process of developing new cancer therapeutics. Known as radiotheranostics, these drugs...
News Apr 30, 2024 Top Stories from Western Switzerland (April 2024) From biotech breakthroughs and the transformation of clinical trials to advancements in eco-friendly materials and renewable energy initiatives, ...
Success stories May 02, 2024 BeiGene promuove l’accesso globale ai trattamenti antitumorali: ecco come Dalla sede europea di Basilea, in Svizzera, BeiGene collabora strategicamente con stakeholder in tutto il mondo per far progredire la ricerc...
News May 10, 2024 BioVersys extends Series C financing round to 44.9 million Swiss francs BioVersys is bolstering its partnership with GSK in order to accelerate the development of alpibectir for the treatment of tuberculosis. GSK is s...